Comparison of Event‐Related Potential Markers in Amyloid Positive vs. Amyloid Negative Patients with Mild Cognitive Impairment (MCI) and Dementia in a general neurological clinic

Abstract

Listen

Translate article

AbstractBackgroundWe used an automated Event Related Potentials (ERP) technique to compare ERP responses in amyloid positive and negative group of 75 patients with Mild Cognitive Impairment (MCI) and Dementia in a general neurological outpatient clinic. Over the years, research labs have repeatedly reported abnormal ERP markers in patients with MCI and dementia. Recent advances in technology have made ERP testing safe, easy to use and low cost, thus rendering it suitable for clinical use. Indeed, ERPs have become more routinely used in clinical assessment of neurological patients with cognitive changes. The possibility that ERP could help identify amyloid status in MCI and dementia patients adds to the potential clinical utility of these biomarkers.MethodPatients with a history of cognitive complains underwent an auditory oddball ERP paradigm in conjunction with routine neurological evaluation and imaging studies. Standard neuropsychological testing were available in most cases. Amyloid PET imaging was done as part of the IDEAS (Imaging Dementia ‐Evidence for Amyloid Scanning) study and provided the readings for amyloid load. ERP responses were analyzed in the context of beta amyloid readings, and in relation to the patients’ degree of cognitive deficits.ResultFinal data analysis will be presented at the time of the conferenceConclusionThe possibility that ERP could help identify amyloid status in MCI and dementia patients adds to the potential clinical utility of these biomarkers. possibility that ERP could help identify amyloid status in MCI and dementia patients adds to the potential clinical utility of these biomarkers.